![](https://scx1.b-cdn.net/csz/news/tmb/2017/inthelabandi.jpg)
In the lab and in the clinic, alisertib with TAK-228 excels against solid tumors
Two University of Colorado Cancer Center studies were presented this weekend at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Meeting in Philadelphia, PA showing that using the drug alisertib along with the ...
Nov 1, 2017
0
0